Type 2 Diabetes & Weight Loss

CONDITION

Metabolic and Endocrine

GENDER

Both males and females

AGE GROUP

From 18

and above

STATUS

Recruiting

Novatrials is seeking overweight participants with type 2 diabetes (T2D) to participate in a weight loss clinical study. The study drug is a once-weekly injection of a potential new weight loss treatment. 

Eligibility Requirements 

The study may be suitable for you if you: 

  • Are aged 18 or over 
  • Have been diagnosed with T2D 
  • Have maintained a stable body weight for at least 3 months 
  • Are not currently on any weight loss medication and have not previously undergone weight loss surgery 

What to Expect 

Participants will undergo: 

  • Screening period: up to 2 weeks (1 visit) 
  • Treatment period: up to 68 weeks (14 visits) 
  • Follow-up period: up to 4 weeks (1 visit) 

Participants will also receive diet and activity advice to support weight loss and health.  

Further Information 

All trial-related care and medication is provided at no cost by our dedicated healthcare team. Travel reimbursement is provided for all study visits at our clinic, located at Suite 301, 99 Pacific Highway Charlestown NSW 2290.  

 

Studies Contact Form

  • This field is hidden when viewing the form

Approved By: Bellberry Human Research Ethics Committee              

Clinical Trial Registry Link: Click Here